MedTrace Logo

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

NCT01656603 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 9999

Last updated 2026-04-13

No results posted yet for this study

Summary

This study will evaluate the safety of infusion of the investigational cord blood units by carefully documenting all infusion-related problems.

Conditions

  • Infusion Reactions

Interventions

BIOLOGICAL

unlicensed CBU

infusion of unlicensed cord blood units

Sponsors & Collaborators

  • New York Blood Center

    lead OTHER

Principal Investigators

  • Eric Gehrie, MD · New York Blood Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01656603 on ClinicalTrials.gov